nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—XDH—Doxorubicin—muscle cancer	0.219	0.408	CbGbCtD
Trifluoperazine—CYP1A2—Dacarbazine—muscle cancer	0.0853	0.159	CbGbCtD
Trifluoperazine—ABCB1—Dactinomycin—muscle cancer	0.0647	0.121	CbGbCtD
Trifluoperazine—CYP1A2—Etoposide—muscle cancer	0.0417	0.0779	CbGbCtD
Trifluoperazine—ABCB1—Vincristine—muscle cancer	0.0398	0.0744	CbGbCtD
Trifluoperazine—ABCB1—Etoposide—muscle cancer	0.0365	0.0681	CbGbCtD
Trifluoperazine—ABCB1—Doxorubicin—muscle cancer	0.0249	0.0465	CbGbCtD
Trifluoperazine—ABCB1—Methotrexate—muscle cancer	0.0241	0.045	CbGbCtD
Trifluoperazine—S100A4—embryo—muscle cancer	0.00786	0.0453	CbGeAlD
Trifluoperazine—S100A4—smooth muscle tissue—muscle cancer	0.00618	0.0356	CbGeAlD
Trifluoperazine—S100A4—renal system—muscle cancer	0.00595	0.0343	CbGeAlD
Trifluoperazine—S100A4—cardiac atrium—muscle cancer	0.00533	0.0307	CbGeAlD
Trifluoperazine—UGT1A4—renal system—muscle cancer	0.00523	0.0301	CbGeAlD
Trifluoperazine—EBPL—head—muscle cancer	0.00504	0.029	CbGeAlD
Trifluoperazine—EBPL—testis—muscle cancer	0.00487	0.0281	CbGeAlD
Trifluoperazine—HTR2A—hindlimb—muscle cancer	0.00482	0.0277	CbGeAlD
Trifluoperazine—Megacolon—Methotrexate—muscle cancer	0.00482	0.048	CcSEcCtD
Trifluoperazine—S100A4—tendon—muscle cancer	0.00465	0.0267	CbGeAlD
Trifluoperazine—CALY—head—muscle cancer	0.00461	0.0266	CbGeAlD
Trifluoperazine—S100A4—bone marrow—muscle cancer	0.0045	0.0259	CbGeAlD
Trifluoperazine—TNNC1—cardiac atrium—muscle cancer	0.00449	0.0258	CbGeAlD
Trifluoperazine—CALY—testis—muscle cancer	0.00446	0.0257	CbGeAlD
Trifluoperazine—S100A4—vagina—muscle cancer	0.00431	0.0248	CbGeAlD
Trifluoperazine—HTR2A—appendage—muscle cancer	0.00413	0.0238	CbGeAlD
Trifluoperazine—S100A4—head—muscle cancer	0.00398	0.0229	CbGeAlD
Trifluoperazine—Pigmentation disorder—Etoposide—muscle cancer	0.00395	0.0394	CcSEcCtD
Trifluoperazine—TNNC1—tendon—muscle cancer	0.00391	0.0225	CbGeAlD
Trifluoperazine—S100A4—testis—muscle cancer	0.00385	0.0221	CbGeAlD
Trifluoperazine—XDH—renal system—muscle cancer	0.00381	0.0219	CbGeAlD
Trifluoperazine—Ileus paralytic—Vincristine—muscle cancer	0.00377	0.0375	CcSEcCtD
Trifluoperazine—TNNC1—testis—muscle cancer	0.00324	0.0186	CbGeAlD
Trifluoperazine—XDH—vagina—muscle cancer	0.00276	0.0159	CbGeAlD
Trifluoperazine—Throat tightness—Etoposide—muscle cancer	0.00269	0.0268	CcSEcCtD
Trifluoperazine—HTR6—head—muscle cancer	0.0024	0.0138	CbGeAlD
Trifluoperazine—Ileus—Vincristine—muscle cancer	0.0023	0.0229	CcSEcCtD
Trifluoperazine—CALM3—smooth muscle tissue—muscle cancer	0.00227	0.013	CbGeAlD
Trifluoperazine—CALM2—embryo—muscle cancer	0.00226	0.013	CbGeAlD
Trifluoperazine—CALM1—embryo—muscle cancer	0.00225	0.013	CbGeAlD
Trifluoperazine—Retinal disorder—Methotrexate—muscle cancer	0.00221	0.0221	CcSEcCtD
Trifluoperazine—Pigmentation disorder—Doxorubicin—muscle cancer	0.00205	0.0204	CcSEcCtD
Trifluoperazine—SIGMAR1—smooth muscle tissue—muscle cancer	0.00203	0.0117	CbGeAlD
Trifluoperazine—CALM3—cardiac atrium—muscle cancer	0.00195	0.0112	CbGeAlD
Trifluoperazine—CALM2—smooth muscle tissue—muscle cancer	0.00178	0.0102	CbGeAlD
Trifluoperazine—CALM1—smooth muscle tissue—muscle cancer	0.00177	0.0102	CbGeAlD
Trifluoperazine—SIGMAR1—cardiac atrium—muscle cancer	0.00175	0.0101	CbGeAlD
Trifluoperazine—HTR1A—renal system—muscle cancer	0.00174	0.01	CbGeAlD
Trifluoperazine—CALM2—renal system—muscle cancer	0.00171	0.00986	CbGeAlD
Trifluoperazine—Aplastic anaemia—Dactinomycin—muscle cancer	0.00171	0.0171	CcSEcCtD
Trifluoperazine—CALM1—renal system—muscle cancer	0.00171	0.00982	CbGeAlD
Trifluoperazine—CALM3—tendon—muscle cancer	0.0017	0.0098	CbGeAlD
Trifluoperazine—Gait disturbance—Vincristine—muscle cancer	0.00167	0.0166	CcSEcCtD
Trifluoperazine—CALM3—bone marrow—muscle cancer	0.00165	0.0095	CbGeAlD
Trifluoperazine—ADRA1A—renal system—muscle cancer	0.00161	0.00925	CbGeAlD
Trifluoperazine—CALM3—vagina—muscle cancer	0.00158	0.0091	CbGeAlD
Trifluoperazine—Sudden death—Methotrexate—muscle cancer	0.00154	0.0154	CcSEcCtD
Trifluoperazine—CALM2—cardiac atrium—muscle cancer	0.00153	0.00883	CbGeAlD
Trifluoperazine—CALM1—cardiac atrium—muscle cancer	0.00153	0.00879	CbGeAlD
Trifluoperazine—SIGMAR1—tendon—muscle cancer	0.00152	0.00876	CbGeAlD
Trifluoperazine—SIGMAR1—bone marrow—muscle cancer	0.00147	0.00849	CbGeAlD
Trifluoperazine—CHRM2—head—muscle cancer	0.00144	0.00828	CbGeAlD
Trifluoperazine—SIGMAR1—vagina—muscle cancer	0.00141	0.00813	CbGeAlD
Trifluoperazine—CALM3—testis—muscle cancer	0.00141	0.00812	CbGeAlD
Trifluoperazine—HTR2C—head—muscle cancer	0.00139	0.00798	CbGeAlD
Trifluoperazine—HTR2A—embryo—muscle cancer	0.00137	0.0079	CbGeAlD
Trifluoperazine—CALM2—tendon—muscle cancer	0.00134	0.0077	CbGeAlD
Trifluoperazine—CALM1—tendon—muscle cancer	0.00133	0.00766	CbGeAlD
Trifluoperazine—CYP1A2—renal system—muscle cancer	0.00133	0.00765	CbGeAlD
Trifluoperazine—CALM2—bone marrow—muscle cancer	0.0013	0.00746	CbGeAlD
Trifluoperazine—HRH1—smooth muscle tissue—muscle cancer	0.00129	0.00744	CbGeAlD
Trifluoperazine—CALM1—bone marrow—muscle cancer	0.00129	0.00742	CbGeAlD
Trifluoperazine—SIGMAR1—testis—muscle cancer	0.00126	0.00726	CbGeAlD
Trifluoperazine—CALM2—vagina—muscle cancer	0.00124	0.00714	CbGeAlD
Trifluoperazine—CALM1—vagina—muscle cancer	0.00124	0.00711	CbGeAlD
Trifluoperazine—HTR1A—head—muscle cancer	0.00117	0.00672	CbGeAlD
Trifluoperazine—CALM2—head—muscle cancer	0.00115	0.0066	CbGeAlD
Trifluoperazine—Dysphagia—Dactinomycin—muscle cancer	0.00114	0.0114	CcSEcCtD
Trifluoperazine—CALM1—head—muscle cancer	0.00114	0.00657	CbGeAlD
Trifluoperazine—Cardiac arrest—Vincristine—muscle cancer	0.00112	0.0112	CcSEcCtD
Trifluoperazine—Urinary retention—Vincristine—muscle cancer	0.00112	0.0112	CcSEcCtD
Trifluoperazine—CALM2—testis—muscle cancer	0.00111	0.00638	CbGeAlD
Trifluoperazine—CALM1—testis—muscle cancer	0.0011	0.00635	CbGeAlD
Trifluoperazine—Pancytopenia—Dactinomycin—muscle cancer	0.00109	0.0108	CcSEcCtD
Trifluoperazine—HTR2A—smooth muscle tissue—muscle cancer	0.00108	0.00621	CbGeAlD
Trifluoperazine—ADRA1A—head—muscle cancer	0.00108	0.00619	CbGeAlD
Trifluoperazine—DRD2—head—muscle cancer	0.00105	0.00607	CbGeAlD
Trifluoperazine—Muscular weakness—Vincristine—muscle cancer	0.00104	0.0104	CcSEcCtD
Trifluoperazine—HTR2A—renal system—muscle cancer	0.00104	0.00598	CbGeAlD
Trifluoperazine—DRD2—testis—muscle cancer	0.00102	0.00586	CbGeAlD
Trifluoperazine—Anaphylactoid reaction—Etoposide—muscle cancer	0.00099	0.00987	CcSEcCtD
Trifluoperazine—HRH1—tendon—muscle cancer	0.000971	0.00559	CbGeAlD
Trifluoperazine—Pancytopenia—Vincristine—muscle cancer	0.000971	0.00967	CcSEcCtD
Trifluoperazine—Ileus—Doxorubicin—muscle cancer	0.000967	0.00964	CcSEcCtD
Trifluoperazine—Agranulocytosis—Dactinomycin—muscle cancer	0.000952	0.00949	CcSEcCtD
Trifluoperazine—Erectile dysfunction—Vincristine—muscle cancer	0.000941	0.00938	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Vincristine—muscle cancer	0.000933	0.0093	CcSEcCtD
Trifluoperazine—Ventricular arrhythmia—Doxorubicin—muscle cancer	0.000925	0.00922	CcSEcCtD
Trifluoperazine—Cardiac arrest—Etoposide—muscle cancer	0.000911	0.00908	CcSEcCtD
Trifluoperazine—HRH1—vagina—muscle cancer	0.000901	0.00519	CbGeAlD
Trifluoperazine—ABCB1—embryo—muscle cancer	0.0009	0.00518	CbGeAlD
Trifluoperazine—Glycosuria—Doxorubicin—muscle cancer	0.000845	0.00842	CcSEcCtD
Trifluoperazine—HRH1—head—muscle cancer	0.000832	0.00479	CbGeAlD
Trifluoperazine—Dysphagia—Etoposide—muscle cancer	0.000828	0.00825	CcSEcCtD
Trifluoperazine—Blood disorder—Doxorubicin—muscle cancer	0.00082	0.00817	CcSEcCtD
Trifluoperazine—Bronchospasm—Etoposide—muscle cancer	0.000814	0.00812	CcSEcCtD
Trifluoperazine—Liver injury—Doxorubicin—muscle cancer	0.000813	0.00811	CcSEcCtD
Trifluoperazine—HTR2A—tendon—muscle cancer	0.000811	0.00467	CbGeAlD
Trifluoperazine—HRH1—testis—muscle cancer	0.000804	0.00463	CbGeAlD
Trifluoperazine—Erythema—Dactinomycin—muscle cancer	0.000797	0.00794	CcSEcCtD
Trifluoperazine—Pancytopenia—Etoposide—muscle cancer	0.000786	0.00784	CcSEcCtD
Trifluoperazine—Amenorrhoea—Doxorubicin—muscle cancer	0.000779	0.00776	CcSEcCtD
Trifluoperazine—HTR2A—vagina—muscle cancer	0.000753	0.00433	CbGeAlD
Trifluoperazine—Aplastic anaemia—Methotrexate—muscle cancer	0.000742	0.0074	CcSEcCtD
Trifluoperazine—Dyskinesia—Doxorubicin—muscle cancer	0.000728	0.00726	CcSEcCtD
Trifluoperazine—Jaundice—Etoposide—muscle cancer	0.00072	0.00717	CcSEcCtD
Trifluoperazine—Leukopenia—Dactinomycin—muscle cancer	0.000714	0.00711	CcSEcCtD
Trifluoperazine—Gynaecomastia—Methotrexate—muscle cancer	0.000707	0.00705	CcSEcCtD
Trifluoperazine—Gait disturbance—Doxorubicin—muscle cancer	0.000701	0.00699	CcSEcCtD
Trifluoperazine—HTR2A—head—muscle cancer	0.000695	0.004	CbGeAlD
Trifluoperazine—Agranulocytosis—Etoposide—muscle cancer	0.000689	0.00687	CcSEcCtD
Trifluoperazine—Hepatocellular injury—Doxorubicin—muscle cancer	0.000685	0.00682	CcSEcCtD
Trifluoperazine—ABCB1—renal system—muscle cancer	0.000681	0.00392	CbGeAlD
Trifluoperazine—HTR2A—testis—muscle cancer	0.000672	0.00387	CbGeAlD
Trifluoperazine—Agitation—Vincristine—muscle cancer	0.000654	0.00652	CcSEcCtD
Trifluoperazine—Photosensitivity—Methotrexate—muscle cancer	0.000653	0.00651	CcSEcCtD
Trifluoperazine—Aplastic anaemia—Doxorubicin—muscle cancer	0.000643	0.00641	CcSEcCtD
Trifluoperazine—Leukopenia—Vincristine—muscle cancer	0.000637	0.00635	CcSEcCtD
Trifluoperazine—Anorexia—Dactinomycin—muscle cancer	0.00062	0.00618	CcSEcCtD
Trifluoperazine—Convulsion—Vincristine—muscle cancer	0.000617	0.00615	CcSEcCtD
Trifluoperazine—Dermatitis exfoliative—Methotrexate—muscle cancer	0.000608	0.00606	CcSEcCtD
Trifluoperazine—Anaphylactoid reaction—Methotrexate—muscle cancer	0.000593	0.00591	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Vincristine—muscle cancer	0.000581	0.00579	CcSEcCtD
Trifluoperazine—Antrafenine—PTGS2—muscle cancer	0.000571	1	CrCbGaD
Trifluoperazine—Photosensitivity—Doxorubicin—muscle cancer	0.000566	0.00564	CcSEcCtD
Trifluoperazine—Decreased appetite—Dactinomycin—muscle cancer	0.000566	0.00564	CcSEcCtD
Trifluoperazine—Fatigue—Dactinomycin—muscle cancer	0.000561	0.00559	CcSEcCtD
Trifluoperazine—Muscle spasms—Etoposide—muscle cancer	0.000555	0.00553	CcSEcCtD
Trifluoperazine—Anorexia—Vincristine—muscle cancer	0.000554	0.00552	CcSEcCtD
Trifluoperazine—Eczema—Doxorubicin—muscle cancer	0.000553	0.00551	CcSEcCtD
Trifluoperazine—Hypotension—Vincristine—muscle cancer	0.000543	0.00541	CcSEcCtD
Trifluoperazine—Increased appetite—Doxorubicin—muscle cancer	0.000529	0.00527	CcSEcCtD
Trifluoperazine—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.000527	0.00525	CcSEcCtD
Trifluoperazine—Insomnia—Vincristine—muscle cancer	0.000526	0.00524	CcSEcCtD
Trifluoperazine—Leukopenia—Etoposide—muscle cancer	0.000516	0.00515	CcSEcCtD
Trifluoperazine—ABCB1—bone marrow—muscle cancer	0.000515	0.00296	CbGeAlD
Trifluoperazine—Body temperature increased—Dactinomycin—muscle cancer	0.000514	0.00513	CcSEcCtD
Trifluoperazine—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.000513	0.00512	CcSEcCtD
Trifluoperazine—Hypoglycaemia—Doxorubicin—muscle cancer	0.000509	0.00507	CcSEcCtD
Trifluoperazine—Decreased appetite—Vincristine—muscle cancer	0.000505	0.00504	CcSEcCtD
Trifluoperazine—Cough—Etoposide—muscle cancer	0.000503	0.00502	CcSEcCtD
Trifluoperazine—Fatigue—Vincristine—muscle cancer	0.000501	0.00499	CcSEcCtD
Trifluoperazine—Convulsion—Etoposide—muscle cancer	0.0005	0.00498	CcSEcCtD
Trifluoperazine—Constipation—Vincristine—muscle cancer	0.000497	0.00495	CcSEcCtD
Trifluoperazine—Asthma—Methotrexate—muscle cancer	0.000496	0.00494	CcSEcCtD
Trifluoperazine—ABCB1—vagina—muscle cancer	0.000493	0.00284	CbGeAlD
Trifluoperazine—Eosinophilia—Methotrexate—muscle cancer	0.000491	0.00489	CcSEcCtD
Trifluoperazine—Hypersensitivity—Dactinomycin—muscle cancer	0.000479	0.00478	CcSEcCtD
Trifluoperazine—Cardiac arrest—Doxorubicin—muscle cancer	0.000472	0.00471	CcSEcCtD
Trifluoperazine—Pancytopenia—Methotrexate—muscle cancer	0.000471	0.00469	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Etoposide—muscle cancer	0.000471	0.00469	CcSEcCtD
Trifluoperazine—Asthenia—Dactinomycin—muscle cancer	0.000467	0.00465	CcSEcCtD
Trifluoperazine—Body temperature increased—Vincristine—muscle cancer	0.000459	0.00458	CcSEcCtD
Trifluoperazine—Skin disorder—Etoposide—muscle cancer	0.000457	0.00456	CcSEcCtD
Trifluoperazine—Erectile dysfunction—Methotrexate—muscle cancer	0.000457	0.00455	CcSEcCtD
Trifluoperazine—ABCB1—head—muscle cancer	0.000456	0.00262	CbGeAlD
Trifluoperazine—Photosensitivity reaction—Methotrexate—muscle cancer	0.000453	0.00451	CcSEcCtD
Trifluoperazine—Anorexia—Etoposide—muscle cancer	0.000449	0.00447	CcSEcCtD
Trifluoperazine—Drowsiness—Methotrexate—muscle cancer	0.000442	0.00441	CcSEcCtD
Trifluoperazine—ABCB1—testis—muscle cancer	0.00044	0.00253	CbGeAlD
Trifluoperazine—Hypotension—Etoposide—muscle cancer	0.00044	0.00439	CcSEcCtD
Trifluoperazine—Muscular weakness—Doxorubicin—muscle cancer	0.000438	0.00437	CcSEcCtD
Trifluoperazine—Asthma—Doxorubicin—muscle cancer	0.000429	0.00428	CcSEcCtD
Trifluoperazine—Dysphagia—Doxorubicin—muscle cancer	0.000429	0.00428	CcSEcCtD
Trifluoperazine—Hypersensitivity—Vincristine—muscle cancer	0.000428	0.00427	CcSEcCtD
Trifluoperazine—Eosinophilia—Doxorubicin—muscle cancer	0.000425	0.00424	CcSEcCtD
Trifluoperazine—Dyspnoea—Etoposide—muscle cancer	0.00042	0.00418	CcSEcCtD
Trifluoperazine—Somnolence—Etoposide—muscle cancer	0.000419	0.00417	CcSEcCtD
Trifluoperazine—Asthenia—Vincristine—muscle cancer	0.000417	0.00416	CcSEcCtD
Trifluoperazine—Agranulocytosis—Methotrexate—muscle cancer	0.000413	0.00411	CcSEcCtD
Trifluoperazine—Rash—Dactinomycin—muscle cancer	0.00041	0.00409	CcSEcCtD
Trifluoperazine—Decreased appetite—Etoposide—muscle cancer	0.000409	0.00408	CcSEcCtD
Trifluoperazine—Pancytopenia—Doxorubicin—muscle cancer	0.000408	0.00406	CcSEcCtD
Trifluoperazine—Fatigue—Etoposide—muscle cancer	0.000406	0.00405	CcSEcCtD
Trifluoperazine—Constipation—Etoposide—muscle cancer	0.000403	0.00401	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000392	0.00391	CcSEcCtD
Trifluoperazine—Weight increased—Doxorubicin—muscle cancer	0.000391	0.0039	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Doxorubicin—muscle cancer	0.000387	0.00386	CcSEcCtD
Trifluoperazine—Nausea—Dactinomycin—muscle cancer	0.000386	0.00385	CcSEcCtD
Trifluoperazine—Dizziness—Vincristine—muscle cancer	0.000384	0.00383	CcSEcCtD
Trifluoperazine—Drowsiness—Doxorubicin—muscle cancer	0.000383	0.00382	CcSEcCtD
Trifluoperazine—Urticaria—Etoposide—muscle cancer	0.000374	0.00373	CcSEcCtD
Trifluoperazine—Jaundice—Doxorubicin—muscle cancer	0.000373	0.00372	CcSEcCtD
Trifluoperazine—Body temperature increased—Etoposide—muscle cancer	0.000372	0.00371	CcSEcCtD
Trifluoperazine—Rash—Vincristine—muscle cancer	0.000366	0.00365	CcSEcCtD
Trifluoperazine—Dermatitis—Vincristine—muscle cancer	0.000366	0.00365	CcSEcCtD
Trifluoperazine—Headache—Vincristine—muscle cancer	0.000364	0.00363	CcSEcCtD
Trifluoperazine—Agranulocytosis—Doxorubicin—muscle cancer	0.000357	0.00356	CcSEcCtD
Trifluoperazine—Hypersensitivity—Etoposide—muscle cancer	0.000347	0.00346	CcSEcCtD
Trifluoperazine—Erythema—Methotrexate—muscle cancer	0.000346	0.00344	CcSEcCtD
Trifluoperazine—Nausea—Vincristine—muscle cancer	0.000345	0.00344	CcSEcCtD
Trifluoperazine—Oedema peripheral—Doxorubicin—muscle cancer	0.000339	0.00337	CcSEcCtD
Trifluoperazine—Asthenia—Etoposide—muscle cancer	0.000338	0.00337	CcSEcCtD
Trifluoperazine—Pruritus—Etoposide—muscle cancer	0.000333	0.00332	CcSEcCtD
Trifluoperazine—Vision blurred—Methotrexate—muscle cancer	0.000326	0.00325	CcSEcCtD
Trifluoperazine—Dizziness—Etoposide—muscle cancer	0.000311	0.0031	CcSEcCtD
Trifluoperazine—Leukopenia—Methotrexate—muscle cancer	0.000309	0.00308	CcSEcCtD
Trifluoperazine—Cough—Methotrexate—muscle cancer	0.000302	0.00301	CcSEcCtD
Trifluoperazine—Convulsion—Methotrexate—muscle cancer	0.000299	0.00298	CcSEcCtD
Trifluoperazine—Erythema—Doxorubicin—muscle cancer	0.000299	0.00298	CcSEcCtD
Trifluoperazine—Rash—Etoposide—muscle cancer	0.000297	0.00296	CcSEcCtD
Trifluoperazine—Dermatitis—Etoposide—muscle cancer	0.000297	0.00296	CcSEcCtD
Trifluoperazine—Headache—Etoposide—muscle cancer	0.000295	0.00294	CcSEcCtD
Trifluoperazine—Nervousness—Doxorubicin—muscle cancer	0.000291	0.0029	CcSEcCtD
Trifluoperazine—Muscle spasms—Doxorubicin—muscle cancer	0.000288	0.00287	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Methotrexate—muscle cancer	0.000282	0.00281	CcSEcCtD
Trifluoperazine—Vision blurred—Doxorubicin—muscle cancer	0.000282	0.00281	CcSEcCtD
Trifluoperazine—Nausea—Etoposide—muscle cancer	0.00028	0.00279	CcSEcCtD
Trifluoperazine—Agitation—Doxorubicin—muscle cancer	0.000275	0.00274	CcSEcCtD
Trifluoperazine—Skin disorder—Methotrexate—muscle cancer	0.000274	0.00273	CcSEcCtD
Trifluoperazine—Anorexia—Methotrexate—muscle cancer	0.000269	0.00268	CcSEcCtD
Trifluoperazine—Leukopenia—Doxorubicin—muscle cancer	0.000268	0.00267	CcSEcCtD
Trifluoperazine—Hypotension—Methotrexate—muscle cancer	0.000264	0.00263	CcSEcCtD
Trifluoperazine—Cough—Doxorubicin—muscle cancer	0.000261	0.0026	CcSEcCtD
Trifluoperazine—Convulsion—Doxorubicin—muscle cancer	0.000259	0.00258	CcSEcCtD
Trifluoperazine—Insomnia—Methotrexate—muscle cancer	0.000255	0.00254	CcSEcCtD
Trifluoperazine—Dyspnoea—Methotrexate—muscle cancer	0.000251	0.00251	CcSEcCtD
Trifluoperazine—Somnolence—Methotrexate—muscle cancer	0.000251	0.0025	CcSEcCtD
Trifluoperazine—Dry mouth—Doxorubicin—muscle cancer	0.000249	0.00248	CcSEcCtD
Trifluoperazine—Decreased appetite—Methotrexate—muscle cancer	0.000245	0.00244	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Doxorubicin—muscle cancer	0.000244	0.00243	CcSEcCtD
Trifluoperazine—Fatigue—Methotrexate—muscle cancer	0.000243	0.00242	CcSEcCtD
Trifluoperazine—Skin disorder—Doxorubicin—muscle cancer	0.000237	0.00236	CcSEcCtD
Trifluoperazine—Anorexia—Doxorubicin—muscle cancer	0.000233	0.00232	CcSEcCtD
Trifluoperazine—Hypotension—Doxorubicin—muscle cancer	0.000228	0.00227	CcSEcCtD
Trifluoperazine—Urticaria—Methotrexate—muscle cancer	0.000224	0.00223	CcSEcCtD
Trifluoperazine—Body temperature increased—Methotrexate—muscle cancer	0.000223	0.00222	CcSEcCtD
Trifluoperazine—Insomnia—Doxorubicin—muscle cancer	0.000221	0.0022	CcSEcCtD
Trifluoperazine—Dyspnoea—Doxorubicin—muscle cancer	0.000218	0.00217	CcSEcCtD
Trifluoperazine—Somnolence—Doxorubicin—muscle cancer	0.000217	0.00216	CcSEcCtD
Trifluoperazine—Decreased appetite—Doxorubicin—muscle cancer	0.000212	0.00212	CcSEcCtD
Trifluoperazine—Fatigue—Doxorubicin—muscle cancer	0.000211	0.0021	CcSEcCtD
Trifluoperazine—Constipation—Doxorubicin—muscle cancer	0.000209	0.00208	CcSEcCtD
Trifluoperazine—Hypersensitivity—Methotrexate—muscle cancer	0.000208	0.00207	CcSEcCtD
Trifluoperazine—Asthenia—Methotrexate—muscle cancer	0.000202	0.00202	CcSEcCtD
Trifluoperazine—Pruritus—Methotrexate—muscle cancer	0.0002	0.00199	CcSEcCtD
Trifluoperazine—Urticaria—Doxorubicin—muscle cancer	0.000194	0.00193	CcSEcCtD
Trifluoperazine—Body temperature increased—Doxorubicin—muscle cancer	0.000193	0.00192	CcSEcCtD
Trifluoperazine—Dizziness—Methotrexate—muscle cancer	0.000186	0.00186	CcSEcCtD
Trifluoperazine—Hypersensitivity—Doxorubicin—muscle cancer	0.00018	0.00179	CcSEcCtD
Trifluoperazine—Rash—Methotrexate—muscle cancer	0.000178	0.00177	CcSEcCtD
Trifluoperazine—Dermatitis—Methotrexate—muscle cancer	0.000178	0.00177	CcSEcCtD
Trifluoperazine—Headache—Methotrexate—muscle cancer	0.000177	0.00176	CcSEcCtD
Trifluoperazine—Asthenia—Doxorubicin—muscle cancer	0.000175	0.00175	CcSEcCtD
Trifluoperazine—Pruritus—Doxorubicin—muscle cancer	0.000173	0.00172	CcSEcCtD
Trifluoperazine—Nausea—Methotrexate—muscle cancer	0.000168	0.00167	CcSEcCtD
Trifluoperazine—Dizziness—Doxorubicin—muscle cancer	0.000161	0.00161	CcSEcCtD
Trifluoperazine—Rash—Doxorubicin—muscle cancer	0.000154	0.00153	CcSEcCtD
Trifluoperazine—Dermatitis—Doxorubicin—muscle cancer	0.000154	0.00153	CcSEcCtD
Trifluoperazine—Headache—Doxorubicin—muscle cancer	0.000153	0.00152	CcSEcCtD
Trifluoperazine—Nausea—Doxorubicin—muscle cancer	0.000145	0.00145	CcSEcCtD
Trifluoperazine—CALM1—Signaling by PDGF—MDM2—muscle cancer	0.000116	0.00061	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by PDGF—MDM2—muscle cancer	0.000116	0.00061	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—KIDINS220—muscle cancer	0.000115	0.000609	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—KIDINS220—muscle cancer	0.000115	0.000609	CbGpPWpGaD
Trifluoperazine—EBP—Metabolism—PTGS2—muscle cancer	0.000115	0.000608	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—FH—muscle cancer	0.000115	0.000606	CbGpPWpGaD
Trifluoperazine—CALM3—B Cell Activation—MDM2—muscle cancer	0.000113	0.000597	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—FH—muscle cancer	0.000111	0.000587	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—FH—muscle cancer	0.000111	0.000587	CbGpPWpGaD
Trifluoperazine—CALM3—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000111	0.000585	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—PTCH1—muscle cancer	0.000111	0.000585	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—PTCH1—muscle cancer	0.00011	0.000582	CbGpPWpGaD
Trifluoperazine—CALM2—B Cell Activation—MDM2—muscle cancer	0.00011	0.000577	CbGpPWpGaD
Trifluoperazine—CALM1—B Cell Activation—MDM2—muscle cancer	0.00011	0.000577	CbGpPWpGaD
Trifluoperazine—CALM3—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.000108	0.000571	CbGpPWpGaD
Trifluoperazine—CALM1—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000107	0.000566	CbGpPWpGaD
Trifluoperazine—CALM2—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000107	0.000566	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—FOXO4—muscle cancer	0.000107	0.000566	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by NGF—KIT—muscle cancer	0.000106	0.000558	CbGpPWpGaD
Trifluoperazine—CALM1—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.000105	0.000553	CbGpPWpGaD
Trifluoperazine—CALM2—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.000105	0.000553	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—FOXO4—muscle cancer	0.000104	0.000547	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—FOXO4—muscle cancer	0.000104	0.000547	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—CNR1—muscle cancer	0.000103	0.000543	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—FOXO4—muscle cancer	0.000103	0.000543	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—CNR1—muscle cancer	0.000103	0.000541	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by NGF—KIT—muscle cancer	0.000102	0.00054	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by NGF—KIT—muscle cancer	0.000102	0.00054	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—FOXO4—muscle cancer	9.96e-05	0.000525	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—FOXO4—muscle cancer	9.96e-05	0.000525	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—PTCH1—muscle cancer	9.74e-05	0.000513	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—PTCH1—muscle cancer	9.58e-05	0.000505	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—IGF2—muscle cancer	9.56e-05	0.000504	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—PTCH1—muscle cancer	9.56e-05	0.000504	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—PTCH1—muscle cancer	9.41e-05	0.000496	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—PTCH1—muscle cancer	9.38e-05	0.000494	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—CNR1—muscle cancer	9.36e-05	0.000493	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—CNR1—muscle cancer	9.31e-05	0.000491	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—IGF2—muscle cancer	9.25e-05	0.000488	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—IGF2—muscle cancer	9.25e-05	0.000488	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CD34—muscle cancer	9.19e-05	0.000485	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—CNR1—muscle cancer	9.05e-05	0.000477	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—CNR1—muscle cancer	8.9e-05	0.000469	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CD34—muscle cancer	8.89e-05	0.000469	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CD34—muscle cancer	8.89e-05	0.000469	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—CNR1—muscle cancer	8.88e-05	0.000468	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—PTCH1—muscle cancer	8.85e-05	0.000467	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	8.83e-05	0.000466	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—CNR1—muscle cancer	8.74e-05	0.000461	CbGpPWpGaD
Trifluoperazine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	8.72e-05	0.00046	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—CNR1—muscle cancer	8.72e-05	0.00046	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—FH—muscle cancer	8.72e-05	0.00046	CbGpPWpGaD
Trifluoperazine—CALM3—Neuronal System—MDM2—muscle cancer	8.5e-05	0.000448	CbGpPWpGaD
Trifluoperazine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	8.41e-05	0.000443	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by NGF—MDM2—muscle cancer	8.34e-05	0.000439	CbGpPWpGaD
Trifluoperazine—CALM2—Neuronal System—MDM2—muscle cancer	8.22e-05	0.000434	CbGpPWpGaD
Trifluoperazine—CALM1—Neuronal System—MDM2—muscle cancer	8.22e-05	0.000434	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—CNR1—muscle cancer	8.22e-05	0.000433	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—CNR1—muscle cancer	8.09e-05	0.000426	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—CNR1—muscle cancer	8.07e-05	0.000425	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by NGF—MDM2—muscle cancer	8.06e-05	0.000425	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by NGF—MDM2—muscle cancer	8.06e-05	0.000425	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—PTCH1—muscle cancer	7.95e-05	0.000419	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—CNR1—muscle cancer	7.94e-05	0.000419	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—FOXO1—muscle cancer	7.92e-05	0.000418	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—CNR1—muscle cancer	7.92e-05	0.000417	CbGpPWpGaD
Trifluoperazine—CALM3—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	7.78e-05	0.00041	CbGpPWpGaD
Trifluoperazine—DRD2—Circadian rythm related genes—TP53—muscle cancer	7.76e-05	0.000409	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—PTCH1—muscle cancer	7.69e-05	0.000406	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—PTCH1—muscle cancer	7.69e-05	0.000406	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—FOXO1—muscle cancer	7.66e-05	0.000404	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—FOXO1—muscle cancer	7.66e-05	0.000404	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—FOXO4—muscle cancer	7.61e-05	0.000401	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—FOXO1—muscle cancer	7.61e-05	0.000401	CbGpPWpGaD
Trifluoperazine—CALM1—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	7.53e-05	0.000397	CbGpPWpGaD
Trifluoperazine—CALM2—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	7.53e-05	0.000397	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—CNR1—muscle cancer	7.47e-05	0.000394	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—FOXO1—muscle cancer	7.36e-05	0.000388	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—FOXO1—muscle cancer	7.36e-05	0.000388	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—ENO2—muscle cancer	7.08e-05	0.000373	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—FH—muscle cancer	6.96e-05	0.000367	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—ENO2—muscle cancer	6.84e-05	0.000361	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—ENO2—muscle cancer	6.84e-05	0.000361	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—CNR1—muscle cancer	6.71e-05	0.000354	CbGpPWpGaD
Trifluoperazine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	6.63e-05	0.000349	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—PTCH1—muscle cancer	6.55e-05	0.000345	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—PTCH1—muscle cancer	6.52e-05	0.000344	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—MED12—muscle cancer	6.5e-05	0.000343	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—CNR1—muscle cancer	6.49e-05	0.000342	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—CNR1—muscle cancer	6.49e-05	0.000342	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—HMGA1—muscle cancer	6.43e-05	0.000339	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—MED12—muscle cancer	6.29e-05	0.000331	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—MED12—muscle cancer	6.29e-05	0.000331	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—FOXO4—muscle cancer	6.25e-05	0.000329	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—HMGA1—muscle cancer	6.22e-05	0.000328	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—HMGA1—muscle cancer	6.22e-05	0.000328	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—IGF2—muscle cancer	6.11e-05	0.000322	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—FOXO4—muscle cancer	6.04e-05	0.000319	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—FOXO4—muscle cancer	6.04e-05	0.000319	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—KIT—muscle cancer	6.04e-05	0.000318	CbGpPWpGaD
Trifluoperazine—XDH—Metabolism—PTGS2—muscle cancer	5.94e-05	0.000313	CbGpPWpGaD
Trifluoperazine—UGT1A4—Metabolism—PTGS2—muscle cancer	5.94e-05	0.000313	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—ENO2—muscle cancer	5.93e-05	0.000312	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—KIT—muscle cancer	5.84e-05	0.000308	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—KIT—muscle cancer	5.84e-05	0.000308	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—KIT—muscle cancer	5.8e-05	0.000306	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—FOXO4—muscle cancer	5.77e-05	0.000304	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—PTCH1—muscle cancer	5.75e-05	0.000303	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—ENO2—muscle cancer	5.73e-05	0.000302	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—ENO2—muscle cancer	5.73e-05	0.000302	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—PTCH1—muscle cancer	5.66e-05	0.000298	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—PTCH1—muscle cancer	5.65e-05	0.000298	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—FOXO4—muscle cancer	5.63e-05	0.000297	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—FOXO1—muscle cancer	5.62e-05	0.000296	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—KIT—muscle cancer	5.61e-05	0.000296	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—KIT—muscle cancer	5.61e-05	0.000296	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—FOXO4—muscle cancer	5.6e-05	0.000295	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—FOXO4—muscle cancer	5.58e-05	0.000294	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—FOXO4—muscle cancer	5.58e-05	0.000294	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—PTCH1—muscle cancer	5.56e-05	0.000293	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—PTCH1—muscle cancer	5.54e-05	0.000292	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CNR1—muscle cancer	5.53e-05	0.000291	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CNR1—muscle cancer	5.5e-05	0.00029	CbGpPWpGaD
Trifluoperazine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	5.01e-05	0.000264	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—FOXO4—muscle cancer	4.95e-05	0.000261	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—MED12—muscle cancer	4.93e-05	0.00026	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—FOXO4—muscle cancer	4.87e-05	0.000257	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—FOXO4—muscle cancer	4.86e-05	0.000256	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CNR1—muscle cancer	4.85e-05	0.000256	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—FOXO4—muscle cancer	4.78e-05	0.000252	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CNR1—muscle cancer	4.78e-05	0.000252	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CNR1—muscle cancer	4.77e-05	0.000251	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—FOXO4—muscle cancer	4.76e-05	0.000251	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—MDM2—muscle cancer	4.75e-05	0.000251	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PTCH1—muscle cancer	4.7e-05	0.000248	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CNR1—muscle cancer	4.69e-05	0.000247	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CNR1—muscle cancer	4.68e-05	0.000247	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—FOXO1—muscle cancer	4.61e-05	0.000243	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—MDM2—muscle cancer	4.6e-05	0.000242	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—MDM2—muscle cancer	4.6e-05	0.000242	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—MDM2—muscle cancer	4.57e-05	0.000241	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PTCH1—muscle cancer	4.54e-05	0.00024	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PTCH1—muscle cancer	4.54e-05	0.00024	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IGF2—muscle cancer	4.52e-05	0.000238	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IGF2—muscle cancer	4.5e-05	0.000237	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—ENO2—muscle cancer	4.49e-05	0.000237	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—FOXO1—muscle cancer	4.46e-05	0.000235	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—FOXO1—muscle cancer	4.46e-05	0.000235	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—MDM2—muscle cancer	4.42e-05	0.000233	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—MDM2—muscle cancer	4.42e-05	0.000233	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—KIT—muscle cancer	4.28e-05	0.000226	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—FOXO1—muscle cancer	4.26e-05	0.000225	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—FOXO1—muscle cancer	4.16e-05	0.000219	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—FOXO1—muscle cancer	4.14e-05	0.000218	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—FOXO1—muscle cancer	4.12e-05	0.000217	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—FOXO1—muscle cancer	4.12e-05	0.000217	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—FOXO4—muscle cancer	4.04e-05	0.000213	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—VEGFA—muscle cancer	4.01e-05	0.000211	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IGF2—muscle cancer	3.97e-05	0.000209	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CNR1—muscle cancer	3.96e-05	0.000209	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—MED12—muscle cancer	3.93e-05	0.000207	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—FOXO4—muscle cancer	3.91e-05	0.000206	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—FOXO4—muscle cancer	3.91e-05	0.000206	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IGF2—muscle cancer	3.91e-05	0.000206	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IGF2—muscle cancer	3.9e-05	0.000205	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—VEGFA—muscle cancer	3.88e-05	0.000204	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—VEGFA—muscle cancer	3.88e-05	0.000204	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CNR1—muscle cancer	3.84e-05	0.000202	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CNR1—muscle cancer	3.84e-05	0.000202	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IGF2—muscle cancer	3.83e-05	0.000202	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IGF2—muscle cancer	3.82e-05	0.000202	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—FOXO1—muscle cancer	3.65e-05	0.000193	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—FOXO1—muscle cancer	3.59e-05	0.000189	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—FOXO1—muscle cancer	3.59e-05	0.000189	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—ENO2—muscle cancer	3.59e-05	0.000189	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—FOXO1—muscle cancer	3.53e-05	0.000186	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—FOXO1—muscle cancer	3.52e-05	0.000186	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—KIT—muscle cancer	3.52e-05	0.000185	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—KIT—muscle cancer	3.4e-05	0.000179	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—KIT—muscle cancer	3.4e-05	0.000179	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—MDM2—muscle cancer	3.37e-05	0.000178	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—KIT—muscle cancer	3.25e-05	0.000171	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IGF2—muscle cancer	3.24e-05	0.000171	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—KIT—muscle cancer	3.17e-05	0.000167	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—KIT—muscle cancer	3.15e-05	0.000166	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—KIT—muscle cancer	3.14e-05	0.000166	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—KIT—muscle cancer	3.14e-05	0.000166	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IGF2—muscle cancer	3.14e-05	0.000165	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IGF2—muscle cancer	3.14e-05	0.000165	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—TP53—muscle cancer	3.03e-05	0.00016	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—FOXO1—muscle cancer	2.98e-05	0.000157	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—TP53—muscle cancer	2.93e-05	0.000155	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—TP53—muscle cancer	2.93e-05	0.000155	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—FOXO1—muscle cancer	2.89e-05	0.000152	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—FOXO1—muscle cancer	2.89e-05	0.000152	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.8e-05	0.000148	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—KIT—muscle cancer	2.78e-05	0.000147	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—MDM2—muscle cancer	2.77e-05	0.000146	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—KIT—muscle cancer	2.74e-05	0.000144	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—KIT—muscle cancer	2.73e-05	0.000144	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—KIT—muscle cancer	2.69e-05	0.000142	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—KIT—muscle cancer	2.68e-05	0.000141	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—MDM2—muscle cancer	2.68e-05	0.000141	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—MDM2—muscle cancer	2.68e-05	0.000141	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—VEGFA—muscle cancer	2.56e-05	0.000135	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—MDM2—muscle cancer	2.56e-05	0.000135	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MDM2—muscle cancer	2.5e-05	0.000132	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MDM2—muscle cancer	2.48e-05	0.000131	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—MDM2—muscle cancer	2.47e-05	0.00013	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—MDM2—muscle cancer	2.47e-05	0.00013	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—PTGS2—muscle cancer	2.46e-05	0.00013	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—PTGS2—muscle cancer	2.38e-05	0.000126	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—PTGS2—muscle cancer	2.38e-05	0.000126	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—KIT—muscle cancer	2.27e-05	0.00012	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—KIT—muscle cancer	2.2e-05	0.000116	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—KIT—muscle cancer	2.2e-05	0.000116	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MDM2—muscle cancer	2.19e-05	0.000116	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MDM2—muscle cancer	2.16e-05	0.000114	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MDM2—muscle cancer	2.15e-05	0.000113	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MDM2—muscle cancer	2.12e-05	0.000112	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MDM2—muscle cancer	2.11e-05	0.000111	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PTGS2—muscle cancer	2.06e-05	0.000109	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PTGS2—muscle cancer	2e-05	0.000105	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PTGS2—muscle cancer	2e-05	0.000105	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—TP53—muscle cancer	1.94e-05	0.000102	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—VEGFA—muscle cancer	1.9e-05	9.99e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—VEGFA—muscle cancer	1.89e-05	9.94e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MDM2—muscle cancer	1.79e-05	9.44e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MDM2—muscle cancer	1.73e-05	9.13e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MDM2—muscle cancer	1.73e-05	9.13e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—VEGFA—muscle cancer	1.66e-05	8.77e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—VEGFA—muscle cancer	1.64e-05	8.63e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—VEGFA—muscle cancer	1.63e-05	8.61e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—VEGFA—muscle cancer	1.61e-05	8.48e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—VEGFA—muscle cancer	1.6e-05	8.45e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PTGS2—muscle cancer	1.56e-05	8.25e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TP53—muscle cancer	1.43e-05	7.55e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TP53—muscle cancer	1.42e-05	7.51e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—VEGFA—muscle cancer	1.36e-05	7.17e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—VEGFA—muscle cancer	1.32e-05	6.93e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—VEGFA—muscle cancer	1.32e-05	6.93e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TP53—muscle cancer	1.26e-05	6.63e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PTGS2—muscle cancer	1.25e-05	6.58e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TP53—muscle cancer	1.24e-05	6.52e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TP53—muscle cancer	1.23e-05	6.51e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TP53—muscle cancer	1.21e-05	6.41e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TP53—muscle cancer	1.21e-05	6.39e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TP53—muscle cancer	1.03e-05	5.42e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TP53—muscle cancer	9.94e-06	5.24e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TP53—muscle cancer	9.94e-06	5.24e-05	CbGpPWpGaD
